SCHEMBL12840872

SCHEMBL12840872

C=C(C)C(=O)OC1(C(CCC)C(C)C)C2CC3CC(C2)CC1C3

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12840745 0.88 TSHR (0.33) TSHR
SCHEMBL4399175 0.86 TSHR (0.33) TSHR
SCHEMBL4399191 0.85 ALDH1A1 (0.32) TSHR
SCHEMBL4399194 0.82 TSHR (0.35) TSHR
SCHEMBL4399164 0.81 TSHR (0.34) TSHR
SCHEMBL17805477 0.80 TSHR (0.34) TSHR
SCHEMBL525443 0.80 TSHR (0.34) TSHR
SCHEMBL4399202 0.80 TSHR (0.39) TSHR
SCHEMBL4399167 0.79 ALDH1A1 (0.32) TSHR
SCHEMBL4403816 0.78 TSHR (0.30) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065040-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065040-A1 PHOTORESIST COMPOSITION C1R, P4HA1, C1S TSHR 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.